U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C14H12FNO3
Molecular Weight 261.2484
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FLUMEQUINE

SMILES

CC1CCC2=CC(F)=CC3=C2N1C=C(C(O)=O)C3=O

InChI

InChIKey=DPSPPJIUMHPXMA-UHFFFAOYSA-N
InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19)

HIDE SMILES / InChI

Molecular Formula C14H12FNO3
Molecular Weight 261.2484
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Flumequine is a synthetic antibiotic, which used to treat urinary tract infections until toxicity studies were reported. Flumequine inhibits bacterial enzyme DNA gyrase (topoisomerase) that is responsible for the supercoiling of DNA, thus bacterial cell growth disrupted by inhibiting nucleic acid synthesis.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Oral bioavailability, tissue distribution and depletion of flumequine in the food producing animal, chicken for fattening.
2008-02
Simultaneous determination of different classes of antibiotics in fish and livestock by CE-MS.
2007-11
Development and validation of an HPLC confirmatory method for residue analysis of ten quinolones in tissues of various food-producing animals, according to the European Union Decision 2002/657/EC.
2007-11
Multiresidue HPLC analysis of ten quinolones in milk after solid phase extraction: validation according to the European Union Decision 2002/657/EC.
2007-10
Simultaneous determination of selected veterinary antibiotics in gilthead seabream (Sparus Aurata) by liquid chromatography-mass spectrometry.
2007-09-15
Improved microbial screening assay for the detection of quinolone residues in poultry and eggs.
2007-08
Determination of quinolone residues in shrimp using liquid chromatography with fluorescence detection and residue confirmation by mass spectrometry.
2007-07-23
Visible-light-Mediated TiO2 photocatalysis of fluoroquinolone antibacterial agents.
2007-07-01
Development of a monoclonal antibody-based broad-specificity ELISA for fluoroquinolone antibiotics in foods and molecular modeling studies of cross-reactive compounds.
2007-06-15
Multiresidue determination of quinolone antibacterials in eggs of laying hens by liquid chromatography with fluorescence detection.
2007-06-01
Separation of fifteen quinolones by high performance liquid chromatography: application to pharmaceuticals and ofloxacin determination in urine.
2007-06
Toxicity evaluation with Vibrio fischeri test of organic chemicals used in aquaculture.
2007-06
Simultaneous determination of trace levels of 10 quinolones in swine, chicken, and shrimp muscle tissues using HPLC with programmable fluorescence detection.
2007-05-16
Multiresidue determination of quinolone and fluoroquinolone antibiotics in fish and shrimp by liquid chromatography/tandem mass spectrometry.
2007-05-04
Biosensor immunoassay for flumequine in broiler serum and muscle.
2007-03-14
Dual biosensor immunoassay-directed identification of fluoroquinolones in chicken muscle by liquid chromatography electrospray time-of-flight mass spectrometry.
2007-03-14
Microbiological detection of 10 quinolone antibiotic residues and its application to artificially contaminated poultry samples.
2007-03
Retention of quinolones on human serum albumin and alpha1-acid glycoprotein HPLC columns: relationships with different scales of lipophilicity.
2007-03
Impacts of waste from concentrated animal feeding operations on water quality.
2007-02
[Residues of tetracycline and quinolones in wild fish living around a salmon aquaculture center in Chile].
2007-02
Biotransformation of flumequine by the fungus Cunninghamella elegans.
2007-02
Adsorption and oxidation of fluoroquinolone antibacterial agents and structurally related amines with goethite.
2007-01
Lack of in vivo mutagenicity and oxidative DNA damage by flumequine in the livers of gpt delta mice.
2007-01
Resistance mechanism against fluoroquinolones in Mycoplasma hyopneumoniae field isolates.
2007
Determination of fluoroquinolones in milk samples by postcolumn derivatization liquid chromatography with luminescence detection.
2006-12-27
Confirmatory and quantitative analysis using experimental design for the extraction and liquid chromatography-UV, liquid chromatography-mass spectrometry and liquid chromatography-mass spectrometry/mass spectrometry determination of quinolones in turkey muscle.
2006-12-01
Multiresidue method for the determination of quinolone antibiotics in bovine raw milk by capillary electrophoresis-tandem mass spectrometry.
2006-11-15
Chromatographic determination of flumequine in food samples by post-column derivatisation with terbium(III).
2006-09-25
Ecotoxicity of mixtures of antibiotics used in aquacultures.
2006-08
Gene expression analysis in mice liver on hepatocarcinogenesis by flumequine.
2006-08
Determination of quinolone residues in chicken and fish by capillary electrophoresis-mass spectrometry.
2006-06
Drug resistance and random amplified polymorphic DNA analysis of Photobacterium damselae ssp. piscicida isolates from cultured Seriola (yellowtail, amberjack and kingfish) in Japan.
2006-06
Simultaneous determination of (fluoro)quinolone antibiotics in kidney, marine products, eggs, and muscle by enzyme-linked immunosorbent assay (ELISA).
2006-04-19
Multiresidue determination of eleven quinolones in milk by liquid chromatography with fluorescence detection.
2006-03-11
Fluoroquinolone-resistant Salmonella sp. in carcasses.
2006-02
Evaluation of the Premi Test and comparison with the One-Plate Test for the detection of antimicrobials in kidney.
2006-02
Efficient approach for the reliable quantification and confirmation of antibiotics in water using on-line solid-phase extraction liquid chromatography/tandem mass spectrometry.
2006-01-20
Determination of fluoroquinolones in chicken tissues by LC-coupled electrospray ionisation and atmospheric pressure chemical ionisation.
2006-01
Evaluation of certain veterinary drug residues in food. Sixty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives.
2006
High-throughput screening for multi-class veterinary drug residues in animal muscle using liquid chromatography/tandem mass spectrometry with on-line solid-phase extraction.
2006
Validation of a novel HPLC sorbent material for the determination of ten quinolones in human and veterinary pharmaceutical formulations.
2005-12
Efficacy of orally administered flumequine in the treatment of vibriosis caused by Listonella anguillarum in atlantic cod Gadus morhua.
2005-11-09
Flumequine in the goat: pharmacokinetics after intravenous and intramuscular administration.
2005-11
Isolation and molecular characterization of quinolone resistant Salmonella spp. from poultry farms.
2005-10-31
Interactions of fluoroquinolone antibacterial agents with aqueous chlorine: reaction kinetics, mechanisms, and transformation pathways.
2005-09-15
Multiresidue method for simultaneous determination of ten quinolone antibacterial residues in multimatrix/multispecies animal tissues by liquid chromatography with fluorescence detection: single laboratory validation study.
2005-09-15
Oxidative transformation of fluoroquinolone antibacterial agents and structurally related amines by manganese oxide.
2005-06-15
Standardization of a broth microdilution susceptibility testing method to determine minimum inhibitory concentrations of aquatic bacteria.
2005-05-20
Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo.
2005-05
Effect of quinolone treatment on selection and persistence of quinolone-resistant Escherichia coli in swine faecal flora.
2005
Patents

Sample Use Guides

400 mg bd. Duration of treatment ranged from 7-15 days
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: It was investigated the potential of flumequine to inhibit eukaryotic topoisomerase II, which is responsible for the double-strand DNA breakage reaction as well as bacterial gyrase, inhibitory effects of flumequine on topoisomerase II were high relative to the influence on bacterial gyrase.
Unknown
Substance Class Chemical
Created
by admin
on Wed Apr 02 09:29:31 GMT 2025
Edited
by admin
on Wed Apr 02 09:29:31 GMT 2025
Record UNII
UVG8VSP2SJ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
APURONE
Preferred Name English
FLUMEQUINE
EP   HSDB   INN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
FLUMEQUINE [USAN]
Common Name English
FLUMEQUINE [MI]
Common Name English
FLUMEQUINE [MART.]
Common Name English
flumequine [INN]
Common Name English
FLUMEQUINE [HSDB]
Common Name English
6,7-DIHYDRO-9-FLUORO-5-METHYL-1-OXO-1H,5H-BENZO(I,J)QUINOLIZINE-2-CARBOXYLIC ACID
Common Name English
1H,5H-BENZO(IJ)QUINOLIZINE-2-CARBOXYLIC ACID, 9-FLUORO-6,7-DIHYDRO-5-METHYL-1-OXO-
Common Name English
Flumequine [WHO-DD]
Common Name English
FLUMEQUINE [EP MONOGRAPH]
Common Name English
NSC-757806
Code English
Classification Tree Code System Code
NCI_THESAURUS C795
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
WHO-VATC QJ01MB07
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
WHO-ATC J01MB07
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
Code System Code Type Description
RXCUI
25112
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY RxNorm
SMS_ID
100000080686
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
ECHA (EC/EINECS)
255-962-6
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
ChEMBL
CHEMBL370252
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
CHEBI
85267
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
FDA UNII
UVG8VSP2SJ
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
DRUG BANK
DB08972
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
EPA CompTox
DTXSID5045623
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
MESH
C012976
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
WIKIPEDIA
FLUMEQUINE
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
EVMPD
SUB07696MIG
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
NCI_THESAURUS
C80639
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
HSDB
7034
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
PUBCHEM
3374
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
CAS
42835-25-6
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
NSC
757806
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
INN
3776
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
MERCK INDEX
m5438
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY Merck Index
DRUG CENTRAL
1197
Created by admin on Wed Apr 02 09:29:31 GMT 2025 , Edited by admin on Wed Apr 02 09:29:31 GMT 2025
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
Related Record Type Details
ACTIVE MOIETY